Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and Hypertension

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Hypertension Reports

• Publication date

  2012-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11906-012-0274-7PMID 22610476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.

  2012cited by this paper
• Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

  2011cited by this paper
• The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

  2011cited by this paper
• Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.

  2011cited by this paper
• Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease

  2010cited by this paper
• Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed?

  2010cited by this paper
• Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

  2009cited by this paper
• Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.

  2009cited by this paper
• Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study

  2009cited by this paper
• Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.

  2008cited by this paper
• Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man

  2008cited by this paper
• Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.

  2008cited by this paper
• Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.

  2007cited by this paper
• Scientific Statement From the American Heart Association Use of Nonsteroidal Antiinflammatory Drugs : An Update for Clinicians: A

  2007cited by this paper
• Frequency of analgesic use and risk of hypertension among men.

  2007cited by this paper
• Paracetamol: new vistas of an old drug.

  2006cited by this paper
• Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

  2006cited by this paper
• Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas

  2006cited by this paper
• Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

  2006cited by this paper
• Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.

  2006cited by this paper
• Blood Pressure Effects of COX-2 Inhibitors

  2006cited by this paper
• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• Mechanism of Action of Paracetamol

  2005cited by this paper
• Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.

  2005cited by this paper
• Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women

  2005cited by this paper
• Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?

  2005cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

  2004cited by this paper
• Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease.

  2003cited by this paper
• Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease

  2003cited by this paper
• Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension

  2003cited by this paper
• Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced Hypertension

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.

  2002cited by this paper
• Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk

  2002cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction

  1998cited by this paper
• Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis

  1994cited by this paper
• A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.

  1993cited by this paper
• Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen.

  1987cited by this paper
• Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients.

  1984cited by this paper
• Mechanism of inhibition of renal prostaglandin production by acetaminophen.

  1979cited by this paper

• Structural Tailoring of Etoricoxib: A spectrochemical, medicinal and pharmacological study

  2025cites this paper
• Effect of acetaminophen on the short-term mortality of hospitalized patients with hypertension: A retrospective cohort study

  2025cites this paper
• Hypertension-Mediated Organ Damage in Relation to Severity of Chronic Low Back Pain in Hypertensive Patients

  2024cites this paper
• Targeting neuro-immune systems to achieve cardiac tissue repair following myocardial infarction: A review of therapeutic approaches from in-vivo preclinical to clinical studies

  2023cites this paper
• Over-The-Counter Remedies in Older Adults: Patterns of Use, Potential Pitfalls, and Proposed Solutions.

  2022cites this paper
• Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension

  2022cites this paper
• Gestational NSAIDs distinctly reprogram cardiac injury in preeclamptic rats: Roles of cyclooxygenase, apoptotic and autophagic trails.

  2022cites this paper
• Title: Comparative Risks of Non-Steroidal Anti-Inflammatory Drugs on Chronic Kidney Disease

  2021cites this paper
• Effects of nitro-butoxyl- and butyl-esters of non-steroidal anti-inflammatory drugs compared with parent compounds on the contractility of digital arterial smooth muscle from the fallow deer (Dama dama)

  2021cites this paper
• Perioperative Schmerztherapie mit Nichtopioidanalgetika

  2021cites this paper
• Perioperative Schmerztherapie mit Nichtopioidanalgetika

  2021cites this paper
• Photocatalytic degradation of organic pollutants by MOFs based materials: A review

  2021cites this paper
• Non-Steroidal Anti-Inflammatory Medicines

  2021cites this paper
• Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD

  2021cites this paper
• Perioperative Schmerztherapie mit Nichtopioidanalgetika

  2021cites this paper
• Developing and Verifying the Efficacy of "Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists": A Randomized Controlled Trial.

  2020cites this paper
• Review on Effects of NSAID`S on Different Systems

  2020cites this paper
• Safety of selective non-steroidal anti-inflammatory drugs: analysis of the last years data

  2020cites this paper
• Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study)

  2019cites this paper
• Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis

  2019cites this paper
• Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

  2019cites this paper
• Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases.

  2018cites this paper
• Secondary Hypertension: Infrequently Considered Aspects—Illicit/Recreational Substances, Herbal Remedies, and Drug-Associated Hypertension

  2018cites this paper
• Novel Group of Imidazole Derivatives as Atypical Selective Cyclooxygenase-2 Inhibitors: Design, Synthesis and Biological Evaluation

  2018cites this paper
• Proinflammatory enzyme soluble epoxide hydrolase bridges obesity to colonic inflammation and potential carcinogenesis

  2018cites this paper
• Hypertension: The role of biochemistry in the diagnosis and management.

  2017cites this paper
• Modulation by NADPH oxidase of the chronic cardiovascular and autonomic interaction between cyclosporine and NSAIDs in female rats

  2017cites this paper
• Cardiovascular and renal interactions between cyclosporine and NSAIDs: Underlying mechanisms and clinical relevance

  2017cites this paper
• Opposite Modulatory Effects of Selective and Non‐Selective Cyclooxygenase Inhibition on Cardiovascular and Autonomic Consequences of Cyclosporine in Female Rats

  2017cites this paper
• The Coxib case: Are EP receptors really guilty?

  2016cites this paper
• [Effect of Nonsteroid Antiinflammatory Drugs on Cardiovascular System].

  2015cites this paper
• Treatment Considerations for Cancer Pain: A Global Perspective

  2015cites this paper
• Systemic Hypertension Induced by Harpagophytum procumbens (devil's claw): A Case Report

  2015influential citation
• Risks of nonsteroidal antiinflammatory drugs ( NSAIDs )

  2015cites this paper
• Towards predictive cardiovascular safety : a systems pharmacology approach

  2014cites this paper
• Towards predictive cardiovascular safety : a systems pharmacology approach

  2014cites this paper
• Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity

  2014cites this paper
• Identification of drug-induced myocardial infarction-related protein targets through the prediction of drug-target interactions and analysis of biological processes.

  2014cites this paper
• Headache types, related morbidity, and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross sectional study.

  2014cites this paper
• Paracetamol: mechanism of action, applications and safety concern.

  2014cites this paper
• Acute Pain Management in the Emergency Department: Emphasis on NSAIDs

  2014cites this paper
• Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.

  2014cites this paper
• Safeguarding older adults from inappropriate over-the-counter medications: the role of community pharmacists.

  2014cites this paper
• Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling

  2014cites this paper
• Renale Denervation als Therapieoption

  2013cites this paper
• The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

  2013cites this paper
• A systematic review of the effect of paracetamol on blood pressure in hypertensive and non‐hypertensive subjects

  2013cites this paper
• Drosophila as a tool for studying the conserved genetics of pain

  2012cites this paper